Abstract
A series of novel benzo[1,2,3]selenadiazole–isoxazole hybrid compounds were designed and synthesized from natural (R)-carvone. These derivatives were synthesized from the selenation reaction between the corresponding semicarbazones and selenium dioxide (SeO2) in the presence of glacial acetic acid as a solvent. The structures of the newly synthesized products were fully characterized by spectroscopic analysis (1H, 13C NMR) and HRMS. All the synthesized compounds were tested in vitro against four human cancer cell lines, fibrosarcoma (HT-1080), lung (A-549) and breast (MCF-7 and MDA-MB-231) carcinoma to evaluate their anticancer activity. Most of the semicarbazones and some of the benzo[1,2,3]selenadiazole–isoxazole hybrids showed interesting cell growth inhibitory activity with IC50 values ranging from 10 to 20 µM. Furthermore, semicarbazone bearing 3-phenylisoxazole nucleus and the benzo[1,2,3]selenadiazole-3-p-chlorophenylisoxazole hybrid exhibited significant antiproliferative activity against HT-1080 cells with IC50 values close to 10.9 ± 1.2 and 18.6 ± 2.6 μM, respectively. Furthermore, the semicarbazone bearing a phenyl group on C3 position of the isoxazole nucleus and the 3-(4-chlorophenyl)-benzo[1,2,3]selenadiazole–isoxazole hybrid had a quite good survival performance against MRC5 cells. The mechanism of action of this latter suggested that it induces apoptosis through caspase-3/7 activation.
Graphical abstract
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bimoussa A, Oubella A, Hachim ME, Fawzi M, Ait Itto My Y, Mentre O, Ketatni EM, Bahsis L, Morjani H, Auhmani A (2021) New enaminone sesquiterpenic: TiCl4-catalyzed synthesis, spectral characterization, crystal structure, Hirshfeld surface analysis, DFT studies and cytotoxic activity. J Mol Struct 1241:130622. https://doi.org/10.1016/j.molstruc.2021.130622
Boudreau MW, Peh J, Hergenrother PJ (2019) Procaspase-3 overexpression in cancer: a paradoxical observation with therapeutic potential. ACS Chem Biol 14:2335–2348. https://doi.org/10.1021/acschembio.9b00338
Brindaban CR, Bubun B (2020) Organoselenium chemistry. De Gruyter. https://doi.org/10.1515/9783110625110
Brough PA, Aherne W, Barril X et al (2008) 4,5-Diarylisoxazole Hsp90 chaperone inhibitors: potential therapeutic agents for the treatment of cancer. J Med Chem 51:196–218. https://doi.org/10.1021/jm701018h
Brown K, Arthur J (2007) Selenium, selenoproteins and human health: a review. Public Health Nutr 4:593–599. https://doi.org/10.1079/PHN2001143
Chen T, Wong Y-S (2009) Selenocystine induces caspase-independent apoptosis in MCF-7 human breast carcinoma cells with involvement of p53 phosphorylation and reactive oxygen species generation. Int J Biochem Cell Biol 41:666–676. https://doi.org/10.1016/j.biocel.2008.07.014
Chen T, Zheng W, Wong Y-S et al (2008) Mitochondria-mediated apoptosis in human breast carcinoma MCF-7 cells induced by a novel selenadiazole derivative. Biomed Pharmacother 62:77–84. https://doi.org/10.1016/j.biopha.2007.12.002
Claudio S (2014) Organoselenium chemistry: between synthesis and biochemistry. Bentham Sci. https://doi.org/10.2174/97816080583891140101
Cui J, Pang L, Wei M et al (2019) Synthesis and antiproliferative evaluation of novel steroid-benzisoselenazolone hybrids. Steroids 152:108502. https://doi.org/10.1016/j.steroids.2019.108502
El Mansouri A-E, Oubella A, Maatallah M (2020) Design, synthesis, biological evaluation and molecular docking of new uracil analogs-1,2,4-oxadiazole hybrids as potential anticancer agents. Bioorg Med Chem Lett 30:127438. https://doi.org/10.1016/j.bmcl.2020.127438
El Mansouri A-E, Oubella A, Dânoun K et al (2021) Discovery of novel furo[2,3-d]pyrimidin-2-one–1,3,4-oxadiazole hybrid derivatives as dual antiviral and anticancer agents that induce apoptosis. Arch Pharm. https://doi.org/10.1002/ardp.202100146
El Mansouri A-E, Oubella A, Mehdi A, Ait Itto My Y, Zahouily M, Morjani H, Lazrek HB (2021b) Design, synthesis, biological evaluation and molecular docking of new 1,3,4-oxadiazole homonucleosides and their double-headed analogs as antitumor agents. Bioorg Chem 108:104558. https://doi.org/10.1016/j.bioorg.2020.104558
Fateh VS and Thomas W (2017) Synthesis of organoselenium compounds with potential biological activities. In: Organoselenium compounds in biology and medicine: synthesis, biological and therapeutic treatments (RSC). https://doi.org/10.1039/9781788011907-00077
Ghosh P, Das J, Sarkar A et al (2012) Oxidation with selenium dioxide: the first report of solvent-selective steroidal aromatization, efficient access to 4β,7α-dihydroxy steroids, and syntheses of natural diaromatic ergosterols. Tetrahedron 68:6485–6491. https://doi.org/10.1016/j.tet.2012.05.110
Guan Q, Yang F, Guo D et al (2014) Synthesis and biological evaluation of novel 3,4-diaryl-1,2,5-selenadiazol analogues of combretastatin A-4. Eur J Med Chem 87:1–9. https://doi.org/10.1016/j.ejmech.2014.09.046
Hachim ME, Oubella A, Byadi S, Fawzi M, Laamari Y, Bahsis L, Aboulmouhajir A, Morjani H, Podlipnik Č, Auhmani A, Ait Itto My Y (2021) Newly synthesized (R)-carvone-derived 1,2,3-triazoles: structural, mechanistic, cytotoxic and molecular docking studies. J Biomol Struct Dyn. https://doi.org/10.1080/07391102.2021.1894984
He L, Ji S, Lai H et al (2015) Selenadiazole derivatives as theranostic agents for simultaneous cancer chemo-/radiotherapy by targeting thioredoxin reductase. J Mater Chem B 3:8383–8393. https://doi.org/10.1039/C5TB01501D
Jacobs JP, Jones CM, Baille JP (1970) Characteristics of a human diploid cell designated MRC-5. Nature 227(5254):168–170. https://doi.org/10.1038/227168a0
Jensen MR, Schoepfer J, Radimerski T et al (2008) NVP-AUY922: a small molecule HSP90 inhibitor with potent antitumor activity in preclinical breast cancer models. Breast Cancer Res 10:R33. https://doi.org/10.1186/bcr1996
Joly F, Ahmed-Lecheheb D, Thiery-Vuillemin A et al (2019) Side effects of chemotherapy for testicular cancers and post-cancer follow-up. Bull Cancer 106:805–811. https://doi.org/10.1016/j.bulcan.2019.04.004
Jong G, ChulKim K (1992) Aromatization of cyclohexenes and cyclohexadienes with selenium dioxide-trimethylsilyl polyphosphate. Tet Lett 42:6363–6366. https://doi.org/10.1016/S0040-4039(00)60974-7
Jong GL, Kap KK (1988) Selenium dioxide catalyzed conversion of alcohols to alkyl chlorides by chlorotrimethylsilane. J Org Chem 15:3634–3637. https://doi.org/10.1021/jo00250a048
Kamal A, Surend RJ, Janaki RM et al (2010) Design, synthesis and biological evaluation of 3,5-diaryl-isoxazoline/isoxazole-pyrrolobenzodiazepine conjugates as potential anticancer agents. Eur J Med Chem 45:3924–3937. https://doi.org/10.1016/j.ejmech.2010.05.047
Kirwan A, Utratna M, O’Dwyer ME, Joshi L, Kilcoyne M (2015) Glycosylation-based serum biomarkers for cancer diagnostics and prognostics. BioMed Res Int. https://doi.org/10.1155/2015/490531
Laamari Y, Oubella A, Bimoussa A, El Mansouri A-E, Ketatni EM, Mentre O, Ait Itto My Y, Morjani H, Khouili M, Auhmani A (2021) Design, hemisynthesis, crystal structure and anticancer activity of 1,2,3-triazoles derivatives of totarol. Bioorg Chem 115:105165. https://doi.org/10.1016/j.bioorg.2021.105165
Lenardão EJ, Santi C et al (2018) Organoselenium compounds as reagents and catalysts to develop new green protocols. New Front Organoselenium Compd. https://doi.org/10.1007/978-3-319-92405-2
Leung D, Abbenante G, Fairlie DP (2000) Protease inhibitors: current status and future prospects. J Med Chem 43:305–341. https://doi.org/10.1021/jm990412m
Liang Y-W, Zheng J, Li X et al (2014) Selenadiazole derivatives as potent thioredoxin reductase inhibitors that enhance the radiosensitivity of cancer cells. Eur J Med Chem 84:335–342. https://doi.org/10.1016/j.ejmech.2014.07.032
Marciscano AE, Ghasemzadeh A, Nirschl TR (2018) Elective nodal irradiation attenuates the combinatorial efficacy of stereotactic radiation therapy and immunotherapy. Clin Cancer Res 20:213–220. https://doi.org/10.1158/1078-0432.CCR-17-3427
Merghoub N, El Btaouri H, Benbacer L et al (2016) Tomentosin induces telomere shortening and caspase-dependant apoptosis in cervical cancer cells. J Cell Biochem 118:1689–1698. https://doi.org/10.1002/jcb.25826
Miller KD, Siegel RL, Lin CC et al (2016) Cancer treatment and survivorship statistics. Cancer J Clin 66:271–289. https://doi.org/10.3322/caac.21349
N’ait OA, Ait Itto My Y, Auhmani A et al (2021) Diastereoselective synthesis of new thiazolyl-Indazole derivatives from R-carvone: a combined experimental and theoretical study. Tetrahedron 78:131830. https://doi.org/10.1016/j.tet.2020.131830
Oubella A, Ait Itto My Y, Auhmani A et al (2019) Diastereoselective synthesis and cytotoxic evaluation of new isoxazoles and pyrazoles with monoterpenic skeleton. J Mol Struct 1198:126924. https://doi.org/10.1016/j.molstruc.2019.126924
Oubella A, Ait Itto My Y, Auhmani A et al (2020a) Crystal structure of (R)-5-[(R)-3-(4-chlorophenyl)-5- methyl-4,5-dihydroisoxazol-5-yl]-2-methylcyclohex-2-enone. Acta Cryst E76:400–403. https://doi.org/10.1107/S2056989020001991
Oubella A, Fawzi M, Auhmani A, Riahi A, Morjani H, Robert A, Ait Itto My Y (2020b) Synthesis and antitumor activity of novel heterocyclic systems with monoterpenic skeleton combining dichlorocyclopropane and 1,3,4-thiadiazole nucleus. ChemistrySelect 5:6403–6406. https://doi.org/10.1002/slct.202001284
Oubella A, El Mansouri A-E, Fawzi M, Bimoussa A, Laamari Y, Auhmani A, Morjani H, Robert A, Riahi A, Ait Itto My Y (2021) Thiazolidinone-linked 1,2,3-triazoles with monoterpenic skeleton as new potential anticancer agents: design, synthesis and molecular docking studies. Bioorg Chem 2021:105184. https://doi.org/10.1016/j.bioorg.2021.105184
Pannek J (2020) Prevention of recurrent urinary tract infections in neurourology. Eur Urol Foc 6:817–819. https://doi.org/10.1016/j.euf.2020.01.015
Pettit GR, Singh SB, Hamel E et al (1989) Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4. Experientia 45:209–211. https://doi.org/10.1007/BF01954881
Pettit GR, Singh SB, Boyd MR et al (1995) Antineoplastic AGENTS 291: isolation and synthesis of combretastatins A-4, A-5, and A-6. J Med Chem 38:1666–1672. https://doi.org/10.1021/jm00010a011
Reddy DB, Reddy AS, Padmavathi V (1998) Synthesis of annelated 1,2,3-selena- or -thia-diazoles. J Chem Res 12:784–785. https://doi.org/10.1039/a804381g
Ríos-Gutiérrez M, Domingo LR, Esseffar M et al (2020) Unveiling the different chemical reactivity of diphenyl nitrilimine and phenyl nitrile oxide in [3+2] cycloaddition reactions with (R)-Carvone through the molecular electron density theory. Molecules 25:1085. https://doi.org/10.3390/molecules25051085
Robert NJ, Diéras V, Glaspy J et al (2011) RIBBON-1: randomized, double-blind, placebo-controlled, phase III trial of chemotherapy with or without bevacizumab for first-line treatment of human epidermal growth factor receptor 2-negative, locally recurrent or metastatic breast cancer. J Clin Oncl 29:1252–1260. https://doi.org/10.1200/JCO.2010.28.0982
Roth HS, Hergenrother PJ (2016) Derivatives of procaspase-activating compound 1 (PAC-1) and their anticancer activities. Current Med Chem 23:201–241. https://doi.org/10.2174/0929867323666151127201829
Ruberte AC, Plano D, Encío I et al (2018) Novel selenadiazole derivatives as selective antitumor and radical scavenging agents. Eur J Med Chem 157:14–27. https://doi.org/10.1016/j.ejmech.2018.07.063
Sairi AMM, Ismail SI, Sukor A et al (2020) Cytotoxicity and Anticancer Activity of Donkioporiella mellea on MRC5 (Normal Human Lung) and A549 (Human Lung Carcinoma) Cells Lines. Evid Based Complement Alternat Med. https://doi.org/10.1155/2020/7415672
Shaaban S, Negm A, Sobh MA et al (2015) Organoselenocyanates and symmetrical diselenides redox modulators: design, synthesis and biological evaluation. Eur J Med Chem 97:190–201. https://doi.org/10.1016/j.ejmech.2015.05.002
Sharpless KB, Young MW, Lauer RF (1973) Reactions of selenoxides: thermal syn-elimination and H218O exchange. Tet Lett 22:1979–1982. https://doi.org/10.1016/S0040-4039(01)96098-8
Shi L, Hu R, Wei Y et al (2012) Anthranilic acid-based diamides derivatives incorporating aryl-isoxazoline pharmacophore as potential anticancer agents: design, synthesis and biological evaluation. Eur J Med Chem 54:549–556. https://doi.org/10.1016/j.ejmech.2012.06.001
ShiahH-S L-S, Juang S-H et al (2007) Mitochondria-mediated and p53-associated apoptosis induced in human cancer cells by a novel selenophene derivative, D-501036. Biochem Pharmacol 73:610–619. https://doi.org/10.1016/j.bcp.2006.10.019
Shin KD, Lee M-Y, Shin D-S et al (2015) Blocking tumor cell migration and invasion with biphenyl isoxazole derivative KRIBB3, a synthetic molecule that inhibits Hsp27 phosphorylation. J Biol Chem 280:41439–41448. https://doi.org/10.1074/jbc.M507209200
Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. Can J Clin 68:7–30. https://doi.org/10.3322/caac.21442
Simoni D, Grisolia G, Giannini G et al (2005) Heterocyclic and phenyl double-bond-locked combretastatin analogues possessing potent apoptosis-inducing activity in HL60 and in MDR cell lines. J Med Chem 48:723–736. https://doi.org/10.1021/jm049622b
Sinha R, El-Bayoumy K (2004) Apoptosis is a critical cellular event in cancer chemoprevention and chemotherapy by selenium compounds. Curr Cancer Drug Targets 4:13–28. https://doi.org/10.2174/1568009043481614
Storey S (2008) Targeting apoptosis: selected anticancer strategies. Nat Rev Drug Discov 7:971–972. https://doi.org/10.1038/nrd2662
Taia A, Essaber M, Oubella A, Aatif A, Bodiguel J, Jamart-Grégoire B, Ait Itto My Y, Morjani H (2020) Synthesis, characterization, and biological evaluation of new heterocyclic systems 1, 2, 3-triazole-isoxazoline from eugenol by the mixed condensation reactions. Synth Commun 50:2052–2065. https://doi.org/10.1080/00397911.2020.1762224
Walker D, Hiebert JD (1967) 2,3-dichloro-5,6-dicyanobenzoquinone and its reactions. J Chem Rev 67:153–195. https://doi.org/10.1021/cr60246a002
Wendel T, Zhen Y, Suo Z et al (2016) The novel HSP90 inhibitor NVP-AUY922 shows synergistic anti-leukemic activity with cytarabine in vivo. Exp Cell Res 340:220–226. https://doi.org/10.1016/j.yexcr.2015.12.017
Xiao J, Gao M, Sun Z et al (2020) Recent advances of podophyllotoxin/epipodophyllotoxin hybrids in anticancer activity, mode of action, and structure-activity relationship: an update (2010–2020). Eur J Med Chem 208:112830. https://doi.org/10.1016/j.ejmech.2020.112830
Xie Q, Zhou Y, Lan G et al (2014) Synthesis and biological evaluation of novel 3,4-diaryl-1,2,5-selenadiazol analogues of combretastatin A-4. Biochem Biophys Res Commun 449:88–93. https://doi.org/10.1016/j.ejmech.2014.09.046
Zhou J, Jin J, Zhang Y et al (2013) Synthesis and antiproliferative evaluation of novel benzoimidazole-contained oxazole-bridged analogs of combretastatin A-4. Eur J Med Chem 68:222–232. https://doi.org/10.1016/j.ejmech.2013.08.006
Zhou M, Ji S, Wu Z et al (2015) Synthesis of selenazolopyridine derivatives with capability to induce apoptosis in human breast carcinoma MCF-7 cells through scavenge of intracellular ROS. Eur J Med Chem 96:92–97. https://doi.org/10.1016/j.ejmech.2015.03.069
Živković MB, Novaković IT, Matić IZ et al (2019) Synthesis and preliminary screening for the biological activity of some steroidal Δ4-Unsaturated semicarbazone derivatives. Steroids 148:36–46. https://doi.org/10.1016/j.steroids.2019.04.010
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Oubella, A., Fawzi, M., Bimoussa, A. et al. Convenient route to benzo[1,2,3]selenadiazole–isoxazole hybrids and evaluation of their in vitro cytotoxicity. Chem. Pap. 76, 2935–2946 (2022). https://doi.org/10.1007/s11696-022-02083-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11696-022-02083-6